Coronavirus disease 2019 (COVID-19) vaccination in patients with cirrhosis: Does it work?
作者信息
Calleri Alberto, Saracco Margherita, Romagnoli Renato, Martini Silvia
机构信息
Gastrohepatology UnitAzienda Ospedaliero-Universitaria Città della Salute e della Scienza di TorinoTurinItaly.
Liver Transplantation Center and General Surgery 2UAzienda Ospedaliero-Universitaria Città della Salute e della Scienza di TorinoTurinItaly.
出版信息
Hepatol Commun. 2022 Jun;6(6):1502-1503. doi: 10.1002/hep4.1931. Epub 2022 Apr 16.
Abstract
摘要
相似文献
1
Coronavirus disease 2019 (COVID-19) vaccination in patients with cirrhosis: Does it work?2019冠状病毒病（COVID-19）在肝硬化患者中的疫苗接种：有效吗？
Hepatol Commun. 2022 Jun;6(6):1502-1503. doi: 10.1002/hep4.1931. Epub 2022 Apr 16.
2
Letter to the editor: Could COVID-19 vaccination reduce postinfection mortality in most patients with cirrhosis?致编辑的信：新冠病毒疫苗接种能否降低大多数肝硬化患者感染后的死亡率？
Hepatology. 2023 Feb 1;77(2):E32. doi: 10.1002/hep.32751. Epub 2022 Sep 3.
3
COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.失代偿期肝硬化患者的 COVID-19 疫苗：一项回顾性队列研究，评估安全性数据和与未接种状态相关的风险因素。
Infect Dis Poverty. 2022 May 16;11(1):56. doi: 10.1186/s40249-022-00982-0.
4
Vaccination against COVID-19 decreases hospitalizations in patients with cirrhosis: Results from a nationwide analysis.接种新冠疫苗可降低肝硬化患者的住院率：一项全国性分析的结果
Liver Int. 2022 Apr;42(4):942-944. doi: 10.1111/liv.15193. Epub 2022 Feb 15.
5
SARS-CoV-2 infection in patients with a normal or abnormal liver.肝脏正常或异常患者的新型冠状病毒2型感染
J Viral Hepat. 2021 Jan;28(1):4-11. doi: 10.1111/jvh.13440. Epub 2020 Dec 1.
6
Protecting Patients With Cirrhosis From Coronavirus Disease 2019: Identifying Gaps in Vaccination Rates.保护肝硬化患者免受2019冠状病毒病侵害：识别疫苗接种率方面的差距。
Liver Transpl. 2021 Nov;27(11):1535-1537. doi: 10.1002/lt.26305. Epub 2021 Oct 5.
7
COVID-19 Vaccination in Patients with Chronic Liver Disease.慢性肝病患者的 COVID-19 疫苗接种。
Viruses. 2022 Dec 13;14(12):2778. doi: 10.3390/v14122778.
8
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.肝移植受者和慢性肝病患者接种新冠疫苗后的抗体反应分析。
J Hepatol. 2021 Dec;75(6):1434-1439. doi: 10.1016/j.jhep.2021.08.008. Epub 2021 Aug 26.
9
Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study.新型冠状病毒疫苗在慢性肝病患者中的安全性和免疫原性（CHESS-NMCID 2101）：一项多中心研究。
Clin Gastroenterol Hepatol. 2022 Jul;20(7):1516-1524.e2. doi: 10.1016/j.cgh.2021.12.022. Epub 2021 Dec 20.
10
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients.肝硬化和肝移植患者第二次接种后针对 SARS-CoV2 的体液和 T 细胞免疫应答。
Clin Gastroenterol Hepatol. 2022 Jan;20(1):162-172.e9. doi: 10.1016/j.cgh.2021.09.003. Epub 2021 Sep 9.
Zotero 插件